Clinical Trials Directory

Trials / Conditions / Stage IIIA Colon Cancer

Stage IIIA Colon Cancer

19 registered clinical trials studyying Stage IIIA Colon Cancer.

StatusTrialSponsorPhase
TerminatedEncorafenib, Binimetinib, and Nivolumab in Treating Microsatellite Stable BRAF V600E Metastatic Colorectal Can
NCT04044430
University of California, San FranciscoPhase 1
CompletedHealth Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer
NCT03154190
Stanford UniversityN/A
CompletedCPI-613 and Fluorouracil in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed by Surg
NCT02232152
Wake Forest University Health SciencesPhase 1
CompletedPrograms to Support You During Chemotherapy (Pro-You)
NCT02148406
Vanderbilt-Ingram Cancer CenterN/A
CompletedFamily Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointe
NCT01846520
City of Hope Medical CenterN/A
TerminatedTelomere Length in Predicting Toxicity in Older Patients With Stage III-IV Colorectal Cancer Undergoing Chemot
NCT01934179
Fox Chase Cancer Center—
CompletedIrinotecan and Alisertib in Treating Patients With Advanced Solid Tumors or Colorectal Cancer
NCT01923337
University of California, DavisPhase 1
CompletedPET-MRI in Diagnosing Patients With Colon or Rectal Cancer
NCT01807117
Case Comprehensive Cancer CenterN/A
CompletedAkt Inhibitor MK2206 in Treating Patients With Previously Treated Colon or Rectal Cancer That is Metastatic or
NCT01802320
National Cancer Institute (NCI)Phase 2
CompletedAdherence to Survivorship Care Guidelines in Health Care Providers for Non-Small Cell Lung Cancer and Colorect
NCT01726296
Fox Chase Cancer CenterN/A
CompletedSurvivorship Care Planning in Patients With Colorectal or Non-Small Cell Lung Cancer
NCT01741636
City of Hope Medical CenterN/A
CompletedGenotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointest
NCT01643499
University of ChicagoPhase 1
CompletedSingle Incision Laparoscopic Surgery in Treating Patients With Colorectal Disease
NCT01656746
Ohio State University Comprehensive Cancer CenterN/A
CompletedGamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid Tumors
NCT01131234
National Cancer Institute (NCI)Phase 1
CompletedErlotinib Hydrochloride in Treating Patients With Stage I-III Colorectal Cancer or Adenoma
NCT00754494
National Cancer Institute (NCI)Phase 2
CompletedSB-715992 in Treating Patients With Advanced or Metastatic Colorectal Cancer
NCT00103311
National Cancer Institute (NCI)Phase 2
CompletedA Phase I, Pharmacological, and Biological Study of OSI-774 in Combination With FOLFOX 4 (5-FU, Leucovorin, an
NCT00060411
National Cancer Institute (NCI)Phase 1
CompletedIrinotecan Compared With Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer
NCT00005036
National Cancer Institute (NCI)Phase 3
WithdrawnPan FGFR Kinase Inhibitor BGJ398 and Combination Chemotherapy in Treating Patients With Untreated Metastatic P
NCT02575508
Roswell Park Cancer InstitutePhase 1 / Phase 2